Evidence map›Paper›PMID 42557487›Full record

ArticleSurgical endoscopy2026

A structured conversion score to guide oncologic colectomy during combined endoscopic-laparoscopic surgery for complex colonic polyps.

Mustafa Oruc, Ozgur Aktas, Metincan Erkaya, Joshua Sommovilla, Salih Karahan, David Liska, Scott R Steele, Michael Valente, Emre Gorgun

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mustafa OrucDepartment of Colorectal Surgery, Cleveland Clinic, Digestive Disease and Surgery Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
Ozgur AktasDepartment of Colorectal Surgery, Cleveland Clinic, Digestive Disease and Surgery Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
Metincan ErkayaDepartment of Colorectal Surgery, Cleveland Clinic, Digestive Disease and Surgery Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
Joshua SommovillaDepartment of Colorectal Surgery, Cleveland Clinic, Digestive Disease and Surgery Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
Salih KarahanDepartment of Colorectal Surgery, Cleveland Clinic, Digestive Disease and Surgery Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
David LiskaDepartment of Colorectal Surgery, Cleveland Clinic, Digestive Disease and Surgery Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
Scott R SteeleDepartment of Colorectal Surgery, Cleveland Clinic, Digestive Disease and Surgery Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
Michael ValenteDepartment of Colorectal Surgery, Cleveland Clinic, Digestive Disease and Surgery Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
Emre GorgunDepartment of Colorectal Surgery, Cleveland Clinic, Digestive Disease and Surgery Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. gorgune@ccf.org.ORCID http://orcid.org/0000-0001-7725-3522

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundManagement of complex colonic polyps with benign preoperative biopsy findings remains challenging when endoscopic resection is technically difficult or oncologic risk is uncertain. Combined endoscopic-laparoscopic surgery (CELS) offers an organ-preserving alternative to oncologic colectomy (OC), yet clear criteria for intraoperative decision-making are lacking. This study aimed to identify predictors of conversion from CELS to OC and malignant pathology and to develop an intraoperative risk score to guide escalation.

methodsA single-center retrospective cohort study included consecutive patients treated between 2014 and 2024 for complex colonic polyps with benign preoperative biopsy findings using an endoscopy-first strategy requiring laparoscopic assistance. The primary endpoint was conversion to OC. Secondary endpoints included pathologic malignancy and ≥ T2 disease. Clinically relevant preoperative and intraoperative variables were analyzed using Firth penalized logistic regression. Internal validation was performed using bootstrap resampling. A 10-point CELS-OC score was derived and integrated into a stepwise operative algorithm.

resultsSeventy patients were included, of whom 25 (35.7%) required conversion to OC. Final pathology revealed malignancy in 20 patients (28.6%). Ulceration or depression (aOR 19.15, 95% CI 3.45-106.36; p < 0.001), lesion size ≥ 40 mm (aOR 6.40, 95% CI 1.35-30.33; p = 0.019), and the non-lifting sign (aOR 5.36, 95% CI 1.05-27.44; p = 0.044) were independently associated with conversion. Ulceration or depression remained predictive of malignancy (aOR 13.07, 95% CI 3.10-55.04; p = 0.001). The score demonstrated strong discrimination for OC conversion (AUC 0.928) and malignancy (AUC 0.874). High-risk lesions (≥ 7 points) had OC conversion and malignancy rates of 93.8% and 75.0%, respectively.

conclusionsIn complex colonic polyps with benign biopsy findings, specific morphologic and intraoperative features are associated with conversion to OC and malignant pathology. The CELS-OC score integrates these predictors into a structured intraoperative framework that may improve organ-preserving selection while maintaining oncologic safety. External validation is needed.

Indexed as

ColectomyColonic NeoplasmsColonic PolypsColonoscopyConversion to Open SurgeryLaparoscopyAgedFemaleHumansMaleMiddle AgedRetrospective StudiesCombined endoscopic laparoscopic surgeryComplex colonic polypsConversion scoreIntraoperative decision-makingOncologic colectomyRisk stratification

Identifiers

PMID42557487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.